{
}
UBS has raised its price target on Universal Health Services, Inc. to $280 from $267 while maintaining a Buy rating. The company operates 27 inpatient acute care hospitals and 343 behavioral health facilities across the U.S., U.K., and Puerto Rico, providing a range of medical services.
Savant Capital LLC increased its stake in Universal Health Services by 255.3% in Q4, now holding 6,345 shares valued at $1.14 million. Other firms, including Abacus Planning Group and Cerity Partners, also raised their stakes significantly. Barclays has lowered its price target for the stock from $271 to $249, while analysts maintain a "Moderate Buy" rating with an average target of $224.57.
Barclays has downgraded Acadia Healthcare's stock rating from Overweight to Equal Weight, lowering the price target from $43 to $35 due to concerns over performance and future prospects. Despite a 9.13% revenue growth over the past year, the company faces challenges, including a decline in revenue per patient day and uncertainty surrounding several facilities. Acadia's fourth-quarter earnings missed expectations, and its 2025 forecasts fell short of Wall Street's projections, prompting a cautious outlook from analysts.
UBS has reiterated a Buy rating for Universal Health Services (UHS), maintaining a price target of $267. The company reported a strong fourth quarter for fiscal 2024, with adjusted EBITDA of $615 million and revenues of $4.11 billion, both exceeding expectations. UHS forecasts 2025 net revenues between $17.02 billion and $17.364 billion, reflecting anticipated growth of 7.5% to 9.7%.
Universal Health Services Inc.
Companies
The information provided herein is generated by experimental artificial intelligence and is for informational purposes only.
ubs raises price target on universal health services maintains buy rating
14:59 28.02.2025
institutional investors increase stakes in universal health services amid mixed analyst ratings
Universal Health Services Inc.
The Goldman Sachs Group Inc. PFD 1/1000 C
Wells Fargo & Company
USA
Maria Ruderman
Show more
14:39 28.02.2025
barclays downgrades acadia healthcare stock rating and lowers price target
14:34 28.02.2025
ubs maintains buy rating for universal health services with strong earnings report
17:14 27.02.2025
Trending
Subcategory
Corporate News
Stock Market Updates
Industry Trends
Banking Regulations
CEO Changes
Global Financial Events
Finance Mergers & Acquisitions
Industry Mergers & Acquisitions
Central Bank Actions
Workplace Trends
Market Analysis and Predictions
Retail and Consumer Goods
Government Economic Policies
Global Trade Developments
Financial Scams and Security
Commodities
Corporate Social Responsibility
Startups & Entrepreneurship
Energy Sector Developments
Employment Reports
Countries:
Companies:
Credit Suisse Strategic Income I
UBS Group AG
JPMorgan Chase & Co.
The Goldman Sachs Group, Inc.
Wells Fargo & Company
Bank of America Corporation
Citigroup Inc.
Morgan Stanley
Barclays PLC
Deutsche Bank RV Global PP
Tesla, Inc.
Apple Inc.
Novartis AG
Volkswagen AG
Microsoft Corporation
BNP Paribas SA
Berkshire Hathaway Inc.
NVIDIA Corporation
UBS AG
Banco Santander, S.A.
Currencies:
United States Dollar
Swiss Franc
Euro
British Pound Sterling
Chinese Yuan
Indian Rupee
Japanese Yen
United Arab Emirates Dirham
Australian Dollar
South Korean Won
Vietnamese Đồng
Hong Kong Dollar
Danish Krone
Polish Złoty
Kuwaiti Dinar
Filipino Peso
Offshore Chinese Yuan
Saudi Riyal
Malaysian Ringgit
Canadian Dollar
People: